Literature DB >> 23383379

Proteolytic processing of the prion protein in health and disease.

Hermann C Altmeppen1, Berta Puig, Frank Dohler, Dana K Thurm, Clemens Falker, Susanne Krasemann, Markus Glatzel.   

Abstract

A variety of physiological functions, not only restricted to the nervous system, are discussed for the cellular prion protein (PrP(C)). A prominent, non-physiological property of PrPC is the conversion into its pathogenic isoform (PrP(Sc)) during fatal, transmissible, and neurodegenerative prion diseases. The prion protein is subject to posttranslational proteolytic processing and these cleavage events have been shown i) to regulate its physiological functions, ii) to produce biologically active fragments, and iii) to potentially influence the course of prion disease. Here, we give an overview on the proteolytic processing under physiological and pathological conditions and critically review what is currently known about the three main cleavage events of the prion protein, namely α-cleavage, β-cleavage, and ectodomain shedding. The biological relevance of resulting fragments as well as controversies regarding candidate proteases, with special emphasis on members of the A-disintegrin-and-metalloproteinase (ADAM) family, will be discussed. In addition, we make suggestions aimed at facilitating clarity and progress in this important research field. The better understanding of this issue will not only answer basic questions in prion biology but will likely impact research on other neurodegenerative diseases as well.

Entities:  

Keywords:  ADAM10; ADAM17; Prion protein; ectodomain shedding; proteolytic processing; α-cleavage; β-cleavage

Year:  2012        PMID: 23383379      PMCID: PMC3560451     

Source DB:  PubMed          Journal:  Am J Neurodegener Dis        ISSN: 2165-591X


  156 in total

1.  Cellular prion protein sensitizes neurons to apoptotic stimuli through Mdm2-regulated and p53-dependent caspase 3-like activation.

Authors:  Erwan Paitel; Robin Fahraeus; Frédéric Checler
Journal:  J Biol Chem       Date:  2003-01-14       Impact factor: 5.157

2.  The mechanism of internalization of glycosylphosphatidylinositol-anchored prion protein.

Authors:  Claire Sunyach; Angela Jen; Juelin Deng; Kathleen T Fitzgerald; Yveline Frobert; Jacques Grassi; Mary W McCaffrey; Roger Morris
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

3.  Essential role of the prion protein N terminus in subcellular trafficking and half-life of cellular prion protein.

Authors:  Max Nunziante; Sabine Gilch; Hermann M Schätzl
Journal:  J Biol Chem       Date:  2002-11-12       Impact factor: 5.157

4.  Prion protein expression modulates neuronal copper content.

Authors:  David R Brown
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

Review 5.  Hereditary prion protein amyloidoses.

Authors:  Bernardino Ghetti; Fabrizio Tagliavini; M Takao; Orso Bugiani; Pedro Piccardo
Journal:  Clin Lab Med       Date:  2003-03       Impact factor: 1.935

6.  The membrane domains occupied by glycosylphosphatidylinositol-anchored prion protein and Thy-1 differ in lipid composition.

Authors:  Britta Brügger; Catriona Graham; Iris Leibrecht; Enrico Mombelli; Angela Jen; Felix Wieland; Roger Morris
Journal:  J Biol Chem       Date:  2003-12-04       Impact factor: 5.157

7.  Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels.

Authors:  Erwan Paitel; Claire Sunyach; Cristine Alves da Costa; Jean-Christophe Bourdon; Bruno Vincent; Frédéric Checler
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

Review 8.  Mammalian prion biology: one century of evolving concepts.

Authors:  Adriano Aguzzi; Magdalini Polymenidou
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

9.  On the same cell type GPI-anchored normal cellular prion and DAF protein exhibit different biological properties.

Authors:  Ruliang Li; Tong Liu; Fukuoka Yoshihiro; Magdalena Tary-Lehmann; Mark Obrenovich; Haydar Kuekrek; Shin-Chung Kang; Tao Pan; Boon-Seng Wong; M Edward Medof; Man-Sun Sy
Journal:  Biochem Biophys Res Commun       Date:  2003-04-04       Impact factor: 3.575

10.  Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.

Authors:  Giovanna Mallucci; Andrew Dickinson; Jacqueline Linehan; Peter-Christian Klöhn; Sebastian Brandner; John Collinge
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

View more
  39 in total

1.  Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry.

Authors:  Eric Vallabh Minikel; Eric Kuhn; Alexandra R Cocco; Sonia M Vallabh; Christina R Hartigan; Andrew G Reidenbach; Jiri G Safar; Gregory J Raymond; Michael D McCarthy; Rhonda O'Keefe; Franc Llorens; Inga Zerr; Sabina Capellari; Piero Parchi; Stuart L Schreiber; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2019-09-26       Impact factor: 5.911

2.  Shedding light on prion disease.

Authors:  Markus Glatzel; Luise Linsenmeier; Frank Dohler; Susanne Krasemann; Berta Puig; Hermann C Altmeppen
Journal:  Prion       Date:  2015       Impact factor: 3.931

3.  A d-enantiomeric peptide interferes with heteroassociation of amyloid-β oligomers and prion protein.

Authors:  Nadine S Rösener; Lothar Gremer; Elke Reinartz; Anna König; Oleksandr Brener; Henrike Heise; Wolfgang Hoyer; Philipp Neudecker; Dieter Willbold
Journal:  J Biol Chem       Date:  2018-08-21       Impact factor: 5.157

Review 4.  A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  Nat Rev Neurosci       Date:  2016-04       Impact factor: 34.870

5.  Prion Efficiently Replicates in α-Synuclein Knockout Mice.

Authors:  Edoardo Bistaffa; Martina Rossi; Chiara Maria Giulia De Luca; Federico Cazzaniga; Olga Carletta; Ilaria Campagnani; Fabrizio Tagliavini; Giuseppe Legname; Giorgio Giaccone; Fabio Moda
Journal:  Mol Neurobiol       Date:  2019-04-30       Impact factor: 5.590

6.  The sheddase ADAM10 is a potent modulator of prion disease.

Authors:  Hermann C Altmeppen; Johannes Prox; Susanne Krasemann; Berta Puig; Katharina Kruszewski; Frank Dohler; Christian Bernreuther; Ana Hoxha; Luise Linsenmeier; Beata Sikorska; Pawel P Liberski; Udo Bartsch; Paul Saftig; Markus Glatzel
Journal:  Elife       Date:  2015-02-05       Impact factor: 8.140

7.  Apparent reduction of ADAM10 in scrapie-infected cultured cells and in the brains of scrapie-infected rodents.

Authors:  Cao Chen; Yan Lv; Bao-Yun Zhang; Jin Zhang; Qi Shi; Jing Wang; Chan Tian; Chen Gao; Kang Xiao; Ke Ren; Wei Zhou; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2014-04-26       Impact factor: 5.590

8.  Engineering a murine cell line for the stable propagation of hamster prions.

Authors:  Matthew E C Bourkas; Hamza Arshad; Zaid A M Al-Azzawi; Ondrej Halgas; Ronald A Shikiya; Mohadeseh Mehrabian; Gerold Schmitt-Ulms; Jason C Bartz; Joel C Watts
Journal:  J Biol Chem       Date:  2019-01-31       Impact factor: 5.157

9.  Guinea Pig Prion Protein Supports Rapid Propagation of Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease Prions.

Authors:  Joel C Watts; Kurt Giles; Daniel J Saltzberg; Brittany N Dugger; Smita Patel; Abby Oehler; Sumita Bhardwaj; Andrej Sali; Stanley B Prusiner
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

Review 10.  PrP overdrive: does inhibition of α-cleavage contribute to PrP(C) toxicity and prion disease?

Authors:  Alex J McDonald; Glenn L Millhauser
Journal:  Prion       Date:  2014-04-10       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.